Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2017 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Other Accumulated Expenses of $728,791 for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 87.1% from $389,605 a year earlier and up 47.7% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Other Accumulated Expenses of $619,604, up 113.4% from FY2025.

  • Other Accumulated Expenses has a four-year compound annual growth rate of -35.7% (FY2022 to FY2026).
  • By fiscal year, Other Accumulated Expenses came in at $290,363 in FY2025 (-49.8%), $578,108 in FY2024 (-86.0%), $4.13 million in FY2023 (+13.8%) and $3.63 million in FY2022.
  • The fiscal Q2 2027 figure ranks as the highest quarterly Other Accumulated Expenses since fiscal Q3 2024.
  • Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with growth averaging 21.8%.
  • The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q4 2026 (growth of 113.4%); the low point was fiscal Q3 2025 (a decline of 95.4%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $493,416 (Q1 2027), $619,604 (Q4 2026) and $403,417 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 728,791.00
Jun 30, 2026 493,416.00
Mar 31, 2026 619,604.00
Dec 31, 2025 403,417.00
Sep 30, 2025 389,605.00
Jun 30, 2025 610,000.00
Mar 31, 2025 290,363.00
Dec 31, 2024 318,513.00
Sep 30, 2024 315,362.00
Jun 30, 2024 324,265.00
Mar 31, 2024 578,108.00
Dec 31, 2023 6.93 Mn
Sep 30, 2023 6.41 Mn
Jun 30, 2023 4.47 Mn
Mar 31, 2023 4.13 Mn
Dec 31, 2022 4.00 Mn
Sep 30, 2022 3.88 Mn
Mar 31, 2022 3.63 Mn
Dec 31, 2019 1.20 Mn
Sep 30, 2019 1.20 Mn
API Access

Elite Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY